IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

INDERPAL S SINGH

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1104829738
CMS profile
276625
Location
GOSHEN, NY

General Payments · PY2018–2024

$215,059.69

  • Reported across 619 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$21,996.00

57 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Cardiovascular Disease NY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,580.00 8
Food and Beverage $1,544.79 44
Travel and Lodging $871.21 5

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $15,551.02 14
Lilly USA, LLC $5,330.00 3
ABIOMED $235.27 4
Abbott Laboratories $192.49 2
Amgen Inc. $162.66 8
NOVARTIS PHARMACEUTICALS CORPORATION $141.80 7
Esperion Therapeutics, Inc. $66.62 4
E.R. Squibb & Sons, L.L.C. $62.49 3
Philips Electronics North America Corporation $62.30 3
BOSTON SCIENTIFIC CORPORATION $46.05 2
Kiniksa Pharmaceuticals International, plc $38.62 2
Acerta Pharma LLC $33.56 2
Stryker Corporation $28.54 1
Lexicon Pharmaceuticals, Inc. $25.16 1
ACIST MEDICAL SYSTEMS, INC. $19.42 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $61,296.97 176
PY2019 $71,117.40 136
PY2020 $23,530.25 69
PY2021 $13,970.40 65
PY2022 $9,507.45 57
PY2023 $13,641.22 59
PY2024 $21,996.00 57

Payment records · PY2024 (57)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $167.50 01/11/2024 Food and Beverage Undisputed 01/23/2026 1124848152 CMS
Abbott Laboratories $24.99 11/06/2024 Food and Beverage Undisputed 01/23/2026 1124848154 CMS
ABIOMED $150.00 05/02/2024 Food and Beverage Undisputed 01/23/2026 1142228669 CMS
ABIOMED $3.15 06/04/2024 Food and Beverage Undisputed 01/23/2026 1142228707 CMS
ABIOMED $42.60 06/07/2024 Food and Beverage Undisputed 01/23/2026 1142228705 CMS
ABIOMED $39.52 10/11/2024 Food and Beverage Undisputed 01/23/2026 1142228793 CMS
Acist Medical Systems, Inc. $19.42 03/07/2024 Food and Beverage Undisputed 01/23/2026 1123312728 CMS
Amgen Inc. $24.55 02/05/2024 Food and Beverage Undisputed 01/23/2026 1111709902 CMS
Amgen Inc. $18.82 02/15/2024 Food and Beverage Undisputed 01/23/2026 1111709904 CMS
Amgen Inc. $23.48 03/20/2024 Food and Beverage Undisputed 01/23/2026 1111709906 CMS
Amgen Inc. $18.61 04/22/2024 Food and Beverage Undisputed 01/23/2026 1111709908 CMS
Amgen Inc. $20.65 06/12/2024 Food and Beverage Undisputed 01/23/2026 1111709910 CMS
Amgen Inc. $16.55 08/06/2024 Food and Beverage Undisputed 01/23/2026 1111709912 CMS
Amgen Inc. $23.11 09/11/2024 Food and Beverage Undisputed 01/23/2026 1111709914 CMS
Amgen Inc. $16.89 11/13/2024 Food and Beverage Undisputed 01/23/2026 1111709916 CMS
AstraZeneca Pharmaceuticals LP $15.78 04/04/2024 Food and Beverage Undisputed 01/23/2026 1105396108 CMS
AstraZeneca Pharmaceuticals LP $17.78 07/25/2024 Food and Beverage Undisputed 01/23/2026 1105502512 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $403.58 01/18/2024 Travel and Lodging Undisputed 01/23/2026 1117874691 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $146.81 02/04/2024 Food and Beverage Undisputed 01/23/2026 1117874687 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $280.12 02/04/2024 Travel and Lodging Undisputed 01/23/2026 1117874689 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $108.78 02/07/2024 Travel and Lodging Undisputed 01/23/2026 1117874681 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $38.29 02/16/2024 Travel and Lodging Undisputed 01/23/2026 1117874677 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $40.44 02/16/2024 Travel and Lodging Undisputed 01/23/2026 1117874679 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $124.50 04/03/2024 Food and Beverage Undisputed 01/23/2026 1117874683 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,850.00 04/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117874693 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,850.00 08/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117874695 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,850.00 09/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117874697 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $125.00 10/10/2024 Food and Beverage Undisputed 01/23/2026 1117874685 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,850.00 10/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117874699 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $33.50 12/02/2024 Food and Beverage Undisputed 01/23/2026 1117874675 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,850.00 12/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117874701 CMS
Boston Scientific Corporation $27.30 10/28/2024 Food and Beverage Undisputed 01/23/2026 1092280588 CMS
Boston Scientific Corporation $18.75 12/03/2024 Food and Beverage Undisputed 01/23/2026 1092280586 CMS
E.R. Squibb & Sons, L.L.C. $19.14 08/27/2024 Food and Beverage Undisputed 01/23/2026 1101260617 CMS
E.R. Squibb & Sons, L.L.C. $21.25 09/10/2024 Food and Beverage Undisputed 01/23/2026 1101260627 CMS
E.R. Squibb & Sons, L.L.C. $22.10 10/24/2024 Food and Beverage Undisputed 01/23/2026 1101260635 CMS
Esperion Therapeutics, Inc. $18.86 02/28/2024 Food and Beverage Undisputed 01/23/2026 1129455626 CMS
Esperion Therapeutics, Inc. $13.72 07/23/2024 Food and Beverage Undisputed 01/23/2026 1129455628 CMS
Esperion Therapeutics, Inc. $16.69 09/17/2024 Food and Beverage Undisputed 01/23/2026 1129455630 CMS
Esperion Therapeutics, Inc. $17.35 11/26/2024 Food and Beverage Undisputed 01/23/2026 1129455632 CMS
Kiniksa Pharmaceuticals International, plc $13.44 04/10/2024 Food and Beverage Undisputed 01/23/2026 1154883459 CMS
Kiniksa Pharmaceuticals International, plc $25.18 09/09/2024 Food and Beverage Undisputed 01/23/2026 1154883501 CMS
Lexicon Pharmaceuticals, Inc. $25.16 07/31/2024 Food and Beverage Undisputed 01/23/2026 1081711675 CMS
Lilly USA, LLC $650.00 02/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135008705 CMS
Lilly USA, LLC $260.00 02/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135009813 CMS
Lilly USA, LLC $4,420.00 02/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135008707 CMS
Novartis Pharmaceuticals Corporation $19.93 03/13/2024 Food and Beverage Undisputed 01/23/2026 1087268383 CMS
Novartis Pharmaceuticals Corporation $20.20 04/17/2024 Food and Beverage Undisputed 01/23/2026 1087268385 CMS
Novartis Pharmaceuticals Corporation $21.70 06/05/2024 Food and Beverage Undisputed 01/23/2026 1087268387 CMS
Novartis Pharmaceuticals Corporation $18.50 08/22/2024 Food and Beverage Undisputed 01/23/2026 1087268391 CMS
Novartis Pharmaceuticals Corporation $21.04 09/18/2024 Food and Beverage Undisputed 01/23/2026 1087268393 CMS
Novartis Pharmaceuticals Corporation $20.45 10/09/2024 Food and Beverage Undisputed 01/23/2026 1087268395 CMS
Novartis Pharmaceuticals Corporation $19.98 12/20/2024 Food and Beverage Undisputed 01/23/2026 1087268397 CMS
Philips North America LLC $16.93 01/17/2024 Food and Beverage Undisputed 01/23/2026 1146919732 CMS
Philips North America LLC $23.96 05/02/2024 Food and Beverage Undisputed 01/23/2026 1146919738 CMS
Philips North America LLC $21.41 06/05/2024 Food and Beverage Undisputed 01/23/2026 1146919736 CMS
Stryker Corporation $28.54 10/23/2024 Food and Beverage Undisputed 01/23/2026 1119982039 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.